Positively Positive - Living with HIV/AIDS:
HIV and AIDS News from around the world
Worldwide, 38 million people are infected with HIV. Since 1981, 76 million people have become infected with HIV and 33 million people infected with HIV have died. One forth of individuals infected with HIV are not aware that they have been infected. 1.7 million individuals worldwide acquired HIV in 2019. AIDS kills more people than any other infectious disease.
Practicing Safe Sex is our best resource in preventing HIV infection through sexual contact.
Sexual contact accounts for 95 percent of all new HIV infections worldwide.
Safe Sex = Disease Prevention - STAY SAFE!
Use A Condom Every Time!
“HIV needs to be in the media each and every day as most people only see snippets of news and these are not effective enough. For this reason, in 2007, I decided to include an HIV/AIDS News page where people could find information on many HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) related issues. I collaborate with individuals, groups and organizations throughout the world, to include their HIV/AIDS news articles, press releases, events, workshops, conferences and more on PositivelyPositive.ca. News items stay on the HIV/AIDS News page for a month, and then go into the HIV/AIDS News Archives.”
— Bradford McIntyre
Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1
GENEVA,13 April 2021 - Disruption to HIV services as high as 75% has been reported in some countries—to prevent increased AIDS-related deaths, HIV services must continue during the COVID-19 pandemic
UNAIDS and the World Health Organization (WHO) have supported mathematical modelling to establish the benefits of continuing HIV services compared to the potential harm of additional COVID-19 transmission. The analysis shows that maintaining HIV services would avert between 19 and 146 AIDS-related deaths per 10 000 people over a 50-year time horizon, while the additional COVID-19-related deaths from exposures related to HIV services would be 0.002 to 0.15 per 10 000 people. The analysis demonstrates that the benefits of continuing to provide HIV services during the COVID-19 pandemic far outweigh the risk of additional COVID-19-related deaths.
Fungal disease diagnosis is life saver for patients with HIV and AIDS
12 April 2021 - A fungal disease diagnostic and educational programme has had a transformational impact on the mortality of HIV patients in Guatemala, according to new research.
And the programme, say scientists at the Asociacio´n de Salud Integral (ASI) in Guatemala City and The University of Manchester, will save lives in countries across the developing world if implemented.
New test better detects reservoir of virus in HIV patients
April 12, 2021 - Study may improve clinical trials of therapeutics aimed at curing human immunodeficiency virus, UW Medicine researcher says.
A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease.
Currently no cure exists for HIV and AIDS. But antiretroviral therapy drugs, or ARTs, effectively suppress the virus to undetectable levels, but when ART is stopped, HIV reactivates to rekindle active infection.
Permanent memorial to those lost to the AIDS crisis to finally be unveiled
APRIL 12, 2021 - MAGGIE BASKA - A permanent memorial for those who lost their lives to the HIV and AIDS crisis will have its home in London’s Tottenham Court Road.
The sculpture will sit in Tottenham Court Road near the former Middlesex Hospital, which was where the UK’s first AIDS unit was opened by Princess Diana in 1987.
APRIL 5, 2021 - MAGGIE BASKA - Prime minister Boris Johnson has been condemned for confusing HIV with “AIDS or whatever” during a live broadcast of the UK government’s COVID briefing.
The prime minister was asked about whether he imagined the UK would still be in a pandemic, considering his personal experience being hospitalised with COVID last year. Johnson was hospitalised in April 2020 after reportedly suffering 10 days of symptoms, and he remained in hospital until 12 April.
Hero volunteers of the AIDS crisis tell their stories at last
12 April 2021 - Sarah Maguire - Forty years since HIV/AIDS began taking lives, stories of the Australian volunteers who cared for the dying during the crisis years have been told in a moving new book co-authored by Macquarie University historian Robert Reynolds.
Jim Battiscombe discovered he was HIV positive in 1990, and spent the first two years of his diagnosis caring for his partner Peter, who had been diagnosed at the same time but quickly developed full-blown AIDS.
For a Life Beyond HIV
April 9, 2021 - For a Life Beyond HIV is a non-promotional and educational virtual congress funded and organized by Gilead Sciences.
This 7-week event will bring world-leading HIV specialists, nurses and other healthcare professionals together with members of the community from across the globe to share and learn in the same environment.
Biden seeks to ramp up funds to beat HIV/AIDS in budget request
April 9, 2021 - by Chris Johnson - President Biden, unveiling on Friday his initial budget request to Congress in the first year of his administration, called for ramping up funds to beat the HIV/AIDS epidemic in the United States, signaling he’d continue the PrEP-centric initiative that began in the previous administration.
Reinfection after hepatitis C cure in people with HIV predicted by sexually transmitted infections
9 April 2021 - Keith Alcorn - Screening for sexually transmitted infections in people coinfected with HIV and hepatitis C during or shortly after completing direct-acting antiviral treatment to cure hepatitis C may predict which patients are at higher risk of hepatitis C reinfection, a study carried out in San Diego reports.
How One Canadian Province Hit Its Lowest Rate of HIV Transmission Ever
APRIL 8,2021 -
Ray Mwareya - Even at a time of other competing pandemic-status viruses, it is possible for a state or country to move from being an HIV hotspot to achieving the slowest transmission rates. British Columbia (BC), a province in Canada, is one such illustrious example.
What are the early symptoms of HIV?
Human immunodeficiency virus (HIV) is a contagious disease that currently has no cure. Without treatment, it can severely weaken a person’s immune system and can be fatal.
According to the Centers for Disease Control and Prevention (CDC)Trusted Source, people with HIV do not always have symptoms in the early stages.
A worldwide epidemic decades before the pandemic: 40 years of AIDS artifacts and stories aim to teach recent history and honor millions lost
April 8,2021 - By Alexandra Pecharich - Social work professor Shed Boren’s labor of love offers lessons and memories through an ambitious new exhibition at the Coral Gables Museum
Huston Ochoa MSW ’20 weeps silently as his former professor and another man unfurl the 12-foot-square, stitched-together fabric. He sees there at the bottom, for the first time in nearly three decades, the colorful rectangle that his 3-year-old self and extended family decorated in honor of his deceased parents.
Researchers gain wisdom, key recommendations, from First Nations People living with HIV/AIDS
8 APRIL 2021 - By Megan Mueller - Through storytelling meetings with First Nations people living with HIV/AIDS, a health researcher gains key policy and funding recommendations — nothing short of a call for action that will help to decolonise the HIV cascade of care for Indigenous Peoples.
Health Professor Sean Hillier, a Mi’kmaw scholar from the Qalipu First Nation, Chair of the Indigenous Council at York University and special advisor to the dean of Health on Indigenous Resurgence, is a driving force for positive change. He is an expert on the impact of policy on health care delivery in First Nations communities and in particular for those living with HIV/AIDS.
NIH experts call for accelerated research to address concurrent HIV and COVID-19 pandemics
April 08, 2021 - The COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevention services, and directly, by threatening individual health. An effective response to these dual pandemics requires unprecedented collaboration to accelerate basic and clinical research, as well as implementation science to expeditiously introduce evidence-based strategies into real-world settings. This message comes from a review article co-authored by Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues published in the Journal of Infectious Diseases.
Laverne Cox, Sterling K. Brown to star in 'The Normal Heart' virtual benefit reading
Apr 8, 2021 - Phillip Zonkel - Laverne Cox, Guillermo Díaz, and Ryan O’Connell are among an all-star cast who will perform a virtual benefit reading of Larry Kramer’s Tony Award winning play “The Normal Heart” that will be directed by Paris Barclay.
HRSA Observes National Youth HIV/AIDS Awareness Day
April 08, 2021 - This Saturday, April 10, is National Youth HIV/AIDS Awareness Day. The Health Resources and Services Administration’s (HRSA) HIV/AIDS Bureau (HAB) observes this day every year to raise awareness of the impact of HIV/AIDS on youth and to highlight the work we are doing to help provide care and treatment for youth and young adults with HIV.
MHRP Phase 2 Clinical Trial Launches to Evaluate IL-15 Agonist as Therapy to Reduce Establishment of HIV Reservoir
SILVER SPRING, Md.- April 8, 2021 - The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research last week launched a Phase 2 clinical trial in Thailand to evaluate an interleukin-15 (IL-15) superagonist, ImmunityBio’s Anktiva® (also called N-803), administered during acute HIV infection as an experimental therapy to target establishment of the HIV reservoir at a very early stage.
AIDSWatch 2021: Molecular HIV Surveillance
April 7, 2021 - AIDS United
Statement by Winnie Byanyima, Executive Director of UNAIDS, on the occasion of World Health Day
7 April 2021 - Winnie Byanyima, Executive Director of UNAIDS and Under-Secretary-General of the United Nations
Ten thousand people die every day because they cannot access health care and the cost of health services mean that every year 100 million people are pushed into extreme poverty paying for them. That equates to three people every second.
To tell or not to tell: why and how women disclose their HIV status with partners
7 April 2021 - Krishen Samuel - Women living with HIV in South Africa cited varied reasons for why they shared or did not share their status with partners. These ranged from disclosing as a way to increase intimacy, using disclosure as a form of confrontation after learning that they had acquired HIV from a partner, to deciding not to disclose as an act of self-preservation. These findings were published by Dr Lario Viljoen from Stellenbosch University and colleagues in Women’s Health.
HIV Activist Andrew Spieldenner on His New Job and the Year Ahead
APRIL 07, 2021 - By Neal Broverman - The new executive director of MPact Global Action for Gay Men’s Health and Rights has as many ideas as he does challenges.
For someone as accomplished as Andrew Spieldenner, Ph.D., it’s refreshing how candid and down-to-earth he remains. The current communications professor at California State University, San Marcos, and the new executive director of MPact Global Action for Gay Men’s Health and Rights — the 15-year-old, Oakland, Calif.-based organization that focuses on the needs of gay and bisexual men living with HIV — spoke to Plus on his first day on the job back in March.
In Memoriam: Alvin H. Baum, Jr. (1930–2021)
April 6, 2021 - Sandy James Planner - Alvin H. Baum, Jr., passed away on March 28, 2021. He was 90 years old, and died of natural causes in his sleep.
People with HIV at high risk for intimate partner violence
Ann Arbor, April 6, 2021 - Intimate partner violence found to be associated with riskier behaviors associated with elevated transmission of HIV, increased depression and anxiety, and poor adherence to HIV treatment, scientists report in the American Journal of Preventive Medicine
New data from the Centers for Disease Control and Prevention (CDC) show that one in four adults with HIV in the United States has experienced intimate partner violence (IPV), which disproportionately affects women and LGBT populations. Further, people with HIV who experienced IPV in the past 12 months were more likely to engage in behaviors associated with elevated HIV transmission risk, were less likely to be engaged in routine HIV care and more likely to seek emergency care services and have poor HIV clinical outcomes. The findings are reported in the American Journal of Preventive Medicine, published by Elsevier.
A Moment, An Image: Vancouver in 1987
April 6, 2021 - Sandy James Planner - This image is a who’s who in Vancouver from 1987. It is the result of a “casting call” to politicians, news media, sports figures, rock stars and well known Vancouverites to come together for a photo that was used in AIDS awareness campaigns.
As CROI 2021 Attests, the PrEP Revolution Is Coming
April 5, 2021 - David Alain Wohl, M.D.- The following is a video and transcript excerpt from an interview conducted with David Alain Wohl, M.D., discussing highlights and clinical takeaway messages from the 2021 Conference on Retroviruses and Opportunistic Infections (CROI 2021), which took place in March. In this video, Wohl talks through new findings on HIV prevention, especially those that aim to expand and transform the options available to people for pre-exposure prophylaxis (PrEP).
Certain high blood pressure medications may alter heart risk in people with HIV
DALLAS, April 5, 2021 - When people with human immunodeficiency virus (HIV) develop high blood pressure, the type of medication chosen for their initial treatment may influence their risk of heart disease, stroke and heart failure, according to new research published today in Hypertension, an American Heart Association journal.
John C. Martin, pioneer of single-pill HIV treatment, dies unexpectedly
Apr 5, 2021 - by Lloyd Lee - 'He was a visionary that really understood medical science'
John C. Martin, former CEO of Gilead Sciences who helped develop the first once-a-day pill to treat HIV while at the helm of the company, died unexpectedly on March 30 after suffering head injuries from a fall the previous day. He was 69.
Boris Johnson fiercely condemned for confusing HIV with ‘AIDS or whatever’
APRIL 5, 2021 - MAGGIE BASKA - Prime minister Boris Johnson has been condemned for confusing HIV with “AIDS or whatever” during a live broadcast of the UK government’s COVID briefing.
The prime minister was asked about whether he imagined the UK would still be in a pandemic, considering his personal experience being hospitalised with COVID last year. Johnson was hospitalised in April 2020 after reportedly suffering 10 days of symptoms, and he remained in hospital until 12 April.
HIV and Insomnia More Likely To Go Together, Regardless of Age
April 5, 2021 - By Heather Boerner - But people with HIV are less likely to be diagnosed and treated for insomnia than their HIV-negative peers.
People living with HIV were five times more likely to have insomnia, but were less likely to be diagnosed and treated for it, than their HIV-negative peers, according to a study by Ken Kunisaki, MD, of the University of Minnesota, and colleagues published in Open Forum Infectious Diseases.
The 'elite controllers' who can naturally suppress HIV
4 Apr 2021 - Research into how some HIV-positive people keep the virus at bay promises to yield new treatment possibilities, from vaccines to gene therapies
The year was 1998 when Joel Blankson encountered a patient he would never forget. Blankson was working in the HIV clinic at John Hopkins School of Medicine, Baltimore, when an HIV-positive woman in her mid-40s arrived for some routine tests.
All the Young Men, the story of HIV/AIDS activist Ruth Coker Burks, is a reminder of the good in humanity
APRIL 3 2021 - In 1987, Princess Diana rose above the problems of family - her own and her husband's - by being seen to meet and shake hands with patients suffering from HIV/AIDS. There was courage in the act, because at that time there was a widespread view that the infection could be spread by casual contact, and medical workers were required to wear layers of protective clothing.
Canada’s Bruce House Continues Its Fight for Persons Living With HIV
April 2, 2021 - Originally known as The AIDS Housing Group of Ottawa, and where those living with AIDS retreated for end-of-life care, Bruce House in Ottawa, Ontario, Canada, has endured for 33 years by adapting its services to fit what is needed at the time, shifting from primarily hospice care to transitional care, and continuously offering support services—even surviving the closure of its original transition house several years ago due to lack of funding.
Researchers devise more efficient, enduring CAR gene therapy to combat HIV
April 1, 2021 - Enrique Rivero - A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
This new approach to CAR T gene therapy — a type of immunotherapy that involves genetically engineering the body’s own blood-forming stem cells to create HIV-fighting T cells — has the potential to not only destroy HIV-infected cells but to create “memory cells” that could provide lifelong protection from infection with the virus that causes AIDS.
Nanozymes that can block HIV reactivation
Apr 1, 2021 /PRNewswire/- Dining Out For Life® Hosted by Subaru is More Meaningful Than Ever
Researchers at the Indian Institute of Science (IISc) have developed artificial enzymes that can successfully block reactivation and replication of the Human Immunodeficiency Virus (HIV) in the host’s immune cells.
Made from vanadium pentoxide nanosheets, these “nanozymes” work by mimicking a natural enzyme called glutathione peroxidase that helps reduce oxidative stress levels in the host’s cells, which is required to keep the virus in check.
More choice in community-based HIV testing leads to higher uptake in South Africa
01 April 2021 - Providing a variety of ways to test for HIV resulted in high rates of young people – particularly young women – coming forward and reduced the gap between men and women.
A South African programme that enabled people to take HIV tests in a variety of community settings, such as homes and workplaces, has resulted in high rates of young people getting tested, particularly young women, and reached more men.
Dine Out (or In) to Give Back on Thursday, April 29
CAMDEN, N.J., March 31, 2021 /PRNewswire/- Dining Out For Life® Hosted by Subaru is More Meaningful Than Ever
In the year since the Covid-19 pandemic forced dramatic changes to our lives, our healthcare providers and restaurants have withstood devastating challenges. The success of the 25th Annual Dining Out For Life® hosted by Subaru is now more crucial than ever to support restaurants and community-basedhealth service organizations dedicated to people living with or affected by HIV/AIDS and other chronic conditions.
GETTING TO THE CORE OF HIV REPLICATION
March 31, 2021 by Jorge Salazar - HIV-1 viral capsid simulations on XSEDE-allocated Stampede2, Bridges, Darwin systems uncover nucleotide entry mechanism
Viruses lurk in the grey area between the living and the nonliving, according to scientists. Like living things, they replicate but they don't do it on their own. The HIV-1 virus, like all viruses, needs to hijack a host cell through infection in order to make copies of itself.
B.A.R. covers HIV and AIDS for 40 years
Mar 31, 2021 - by Liz Highleyman - AIDS first came to the world's attention with a June 5, 1981, report from the U.S. Centers for Disease Control and Prevention about five cases of Pneumocystis pneumonia (PCP) among young gay men in Los Angeles. A second report on cases of PCP and Kaposi sarcoma in New York City and California followed a month later.
The City Losing Its Children to H.I.V.
Mar 31, 2021 - By Helen Ouyang - A pediatric outbreak in a remote Pakistan city shows the urgency of global health after Covid.
One day in February 2019, Nazeer Shah carried his 1-year-old daughter, Eman, into a medical clinic. The doctor there, Imran Arbani, was immediately alarmed: The girl was limp and lethargic, her head flopped over on her father’s shoulder. Her breathing was shallow and fast. She was asleep, hard to rouse, except when she woke to cough. She drooled from her mouth. Her tongue was covered with a thick white coating, which Arbani recognized as thrush, a condition that usually indicates a weakened immune system. At around 11 pounds, she was frighteningly underweight.
Fear of HIV disclosure and lack of referrals means that the pain of many Black women with HIV is unaddressed
31 March 2021 - Bakita Kasadha - Specific clinical pathways to pain management and implicit bias training for healthcare providers are needed to ensure people with HIV receive appropriate care for chronic pain, argue Venetia Baker of King’s College London and colleagues in AIDS Care. Findings showed that Black people, especially women, were less likely to be referred for specialist pain management than their White male counterparts. Moreover, participants feared stigma if they shared their HIV status with non-HIV specialists.
Bigo Live Continues Commitment to The Trevor Project, Raises Awareness Around International Transgender Day of Visibility
LOS ANGELES, March 30, 2021 /PRNewswire/ -- $5,000 Donation and Trans Voices Live House on Platform to Further LGBTQ Cause
Bigo Live, a global leader in live streaming and entertainment, is pleased to announce it is pledging $5,000 to The Trevor Project, the world's largest suicide prevention and crisis intervention organization for LGBTQ (lesbian, gay, bisexual, transgender, queer and questioning) young people. This donation marks the company's continued commitment to The Trevor Project which kicked off with World AIDS Day initiatives in 2020. In honor of the International Transgender Day of Visibility, Bigo Live will be hosting a Trans Voices Multiguest panel on March 31 at 4:00 p.m. PST, featuring prominent transgender members of the Bigo Live community.
Living With HIV? Life Insurance Is Available but Limited
Mar 29, 2021 - Ben Moore - For decades, many people living with HIV were denied life insurance coverage, deemed too risky to insure. To this day, most life insurance applications ask applicants to answer “yes” if they are HIV-positive, and many companies deny coverage to those who do.
Cases of sexually transmitted diseases decline in pandemic, but research suggests they could rise again soon
March 29, 2021 - SAN DIEGO - Nationally, in April 2020, reported cases of chlamydia, gonorrhea and early syphilis decreased by 47%, 33% and 30% respectively from the year prior.
Data collected during the COVID-19 pandemic suggests reported cases of sexually transmitted diseases have declined, but experts at UC San Diego's AntiViral Research Center on Monday said rates could soon be on the rise again.
Diabetes drug may be a new weapon against HIV
CHAPEL HILL, NC, March 29, 2021 - Research from the UNC School of Medicine lab of Jenny Ting, PhD, shows that widely used drug metformin reduces metabolism of infected T cells to suppress HIV replication.
A team led by scientists at the UNC School of Medicine discovered an important vulnerability of the AIDS-causing retrovirus HIV, and has shown in preclinical experiments that a widely used diabetes drug, metformin, seems able to exploit this vulnerability.
Chicago: AHF Health Center-Lakeview to Open March 31st
March 29, 2021 - CHICAGO--(BUSINESS WIRE)-- Lakeview’s Boystown District new facilities expand AHF’s existing onsite services, which include a full-service AHF Pharmacy and an Out of The Closet Thrift Store, AHF’s 20th store in 8 states, and first in Illinois
AIDS Healthcare Foundation (AHF), the world’s largest global HIV/AIDS organization, is proud to be expanding services in the city of Chicago, IL. What will now be known as AHF Health Center-Lakeview, this unique hybrid model clinic will be housed within the existing AHF Out of the Closet Thrift Store, with Dr. James Lagucik, DO as the onsite provider.
Formal Transition Plans Essential For Youths With HIV Moving to Adult Care
MARCH 29, 2021 - By Karen Blum - Many youths living with HIV disengage from medical care at some point, and for a significant number of people this happens during the transition from pediatric/adolescent to adult clinics. A number of infectious disease programs have protocols to help pave the way for their patients and keep them engaged, but experts say more education is needed for patients and health providers.
Curtis Smith Turned His AIDS Loss and Pain Into Service to Others
March 29, 2021 - Tim Murphy - Occasionally, while covering a story, you stumble on someone absolutely remarkable in the HIV/AIDS world who you’ve never heard of before. Such was my case with Curtis Smith, 56, the founder and CEO of Families Living with AIDS Care Center (FLACC), an HIV services agency in Hemet, California, about two hours southeast of Los Angeles. Smith founded the agency in 2004, when he, his wife, and his daughter were extremely ill due to AIDS. They’d gone unaware of lifesaving services for too long—and Smith was determined that would never happen again to anyone in need in the Inland Empire region.
When I Was Young
March 29, 2021 - By Oriol R. Gutierrez Jr. - Young people account for 21% of new HIV diagnoses annually. Our April/May issue looks at ways to raise HIV awareness among youth.
I’m not what you’d call a very dramatic person (although my partner would likely disagree). However, I will admit to getting incensed from time to time. The past few years certainly gave me good reasons to scream.
In trying to contain COVID-19, we could be missing spread of HIV, hepatitis C and syphilis, experts warn
Mar 26, 2021 - For more than a year, the COVID-19 pandemic has shifted health-care workers and resources away from stopping the spread of other infectious diseases, including HIV, hepatitis C and sexually transmitted infections such as syphilis.
AIDS Exhibition Virtual Opening Now Available Online
March 25, 2021 - If you missed the virtual opening of the latest Program for Art in Public Spaces exhibition, you can view it online. The March 4 virtual opening of Community in a Time of Crisis: Yale, New Haven, and HIV/AIDS, 1981-1996 includes a virtual tour of the exhibition. The Program for Art in Public Spaces (PAPS) website also has links to previous events and current exhibits. PAPS has been made possible with support from the YSM dean’s office.
March 25, 2021 - By Rachel Otwell -Bill aims to lead with science, not fear
In Illinois, engaging in certain activities as a person living with HIV can be a felony, punishable by a prison sentence and $25,000 fine. But public health experts say the law is harmful and outdated. Advocates for change say it is ineffective at stopping the spread of HIV, and instead acts to increase shame and stigma.
Operation Triple Zero Promotes Positive Action for Youth Living with HIV
Mar 25, 2021 - The adolescent stage of life is often associated with physical and emotional stresses, which can be even more challenging for adolescents living with HIV.
UNAIDS Board adopts new global AIDS strategy which paves the way to end AIDS by 2030
GENEVA, 25 March 2021 - The new Global AIDS Strategy 2021–2026, End Inequalities, End AIDS, is a bold approach that uses an inequalities lens to close the gaps preventing progress to end AIDS
The UNAIDS Programme Coordinating Board (PCB) has adopted by consensus a new Global AIDS Strategy 2021–2026 to get every country and every community on track to end AIDS as a public health threat by 2030. The strategy was adopted by the PCB during a special session, chaired by the Minister of Health of Namibia, held on 24 and 25 March 2021.
Vaccine regimen fails to prevent HIV-1 infection in South Africa
MARCH 25, 2021 - (HealthDay) - A canarypox-protein HIV vaccine regimen (ALVAC-HIV) plus bivalent subtype C gp120-MF59 adjuvant does not prevent HIV-1 infection among adults in South Africa, according to a study published in the March 25 issue of the New England Journal of Medicine.
Canadian Nonprofits Redefine their Fundraising with OneCause Technology
INDIANAPOLIS, March 24, 2021 /PRNewswire/ -- OneCause, a leader in event and online fundraising, today announced it is expanding access for its Virtual Event Center solution to help Canadian nonprofits streamline the digital giving experience. The software provider continues to grow its footprint in the Canadian charitable sector after successfully launching peer-to-peer and online fundraising solutions in 2018.
Bridging lessons from the HIV/AIDS pandemic to COVID-19
24 March 2021 - The HIV/AIDS epidemic offers lessons for today’s COVID-19 pandemic. The Cold Spring Harbor Laboratory (CSHL) Center for Humanities & History of Modern Biology captured some of those lessons in a 2016 CSHL conference, “HIV/AIDS Research: Its History and Future.” In 2021, they developed a new kind of annotated digital archive that allows readers to easily look up and analyze keywords used in talks at the conference. The project, titled “Oral Histories of Biology, Medicine, and Pandemic Response,” was led by the executive director of the CSHL Libraries & Archives Ludmila Pollock and supported by a U.S. National Endowment for the Humanities CARE grant.
Low CD4 cell count linked to increased risk of cancer among people with HIV in South Africa
24 March 2021 - Michael Carter - Immune suppression is associated with an increased risk of numerous infection-related cancers among people with HIV in South Africa, investigators report in Clinical Infectious Diseases. There was a strong association between a lower CD4 cell count and the incidence of Kaposi's sarcoma, non-Hodgkin lymphoma, cervical cancer and other cancers linked to human papillomavirus (HPV), as well as conjunctival cancer (a malignancy of the eye). In addition, there was some evidence that a lower CD4 cell count increased the risk of a small number of cancers not thought to be related to infections, especially cancer of the oesophagus (food pipe).
Conversation with the Creator and Cast of It’s a Sin and amfAR
March 24, 2021 - amfAR, The Foundation for AIDS Research, will be hosting a very special virtual conversation with the creator, cast, and executive producer of the HBO Max limited series, It’s a Sin on Thursday, March 25 at 7pm EDT. This free virtual event will stream on amfAR's official YouTube page.
Brazilian Man With HIV Is No Longer in Remission
March 23, 2021 - By Liz Highleyman - The São Paolo Patient is no longer HIV-free after more than 15 months off treatment, but was it a relapse or reinfection?
A Brazilian man who last summer had no evidence of remaining HIV after more than a year off antiretroviral treatment once again had detectable viral load a few months later, according to a report at the recent Conference on Retroviruses and Opportunistic Infections.
$3M HIV Discrimination Lawsuit Filed Against Morehouse College
March 23, 2021 - By Trenton Straube - A student claims Atlanta’s Morehouse College did not accept him into an academic program because he has HIV.
A former student at Morehouse College in Atlanta filed an HIV discrimination lawsuit against the historically Black men’s liberal arts school seeking over $3 million in emotional distress damages, reports The Atlanta Journal-Constitution.
Robert Gallo, Co-Discoverer of HIV, Delivers Prestigious Uniformed Services University Packard Award Lecture
22-Mar-2021 - Newswise - Bethesda, MD - Dr. Robert C. Gallo, the Homer and Martha Gudelsky Distinguished Professor in Medicine, director and co-founder of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, and the co-Founder and International Scientific Advisor of the Global Virus Network, presented “From T Cells and Human Retroviruses to the SARS-CoV-2 Pandemic and Innate Immunity” as the 2021 David Packard Award Lecturer at the Uniformed Services University of the Health Sciences (USU), Monday, March 22.
Why are transgender people at higher risk of HIV?
March 22, 2021 - by Zawn Villines - HIV is a virus t22 MARCH 2021 hat alters the immune system and can increase the impact of other infections and diseases. Without treatment, HIV may progress to stage 3, an advanced stage commonly known as AIDS. Transgender people are at a higher risk of HIV and may not have access to adequate care.
Amid Hate Crimes, Asians and Pacific Islanders in HIV Say Relatively Low Numbers Shouldn’t Equal Invisibility
March 22, 2021 - Tim Murphy - A few months into the COVID-19 pandemic, New York City’s Chinatown-based Apicha Community Health Center, which began in 1989 as the Asian and Pacific Islander Coalition on HIV/AIDS, informally collected stories from its staff about their pandemic experiences.
81m condoms distributed in Zimbabwe last year
22 MARCH 2021 - Thandeka Moyo-Ndlovu, Health Reporter - A STAGGERING 81 million condoms were distributed in Zimbabwe last year as the country strives to achieve global HIV testing and condom use targets by 2030.
Ukraine reports nearly 1400 HIV cases in February
March 21, 2021 - by NEWS DESK - Ukrainian health officials reported in February 2021, 1,395 new cases of HIV infection were officially registered in Ukraine.
In addition, 389 patients were diagnosed with AIDS, and 123 people died of AIDS.
US invests $85tr globally in fight against HIV/AIDS in 18 years
21 March 2021 - By Isa Abdulsalami Ahovi, Jos - United States (US) Ambassador to Nigeria, Mary Beth Leonard, yesterday, revealed that US government, through the President’s Emergency Plan for AIDS Relief (PEPFAR) has invested more than $85tr in its fight against HIV/AIDS globally.
Quilt ceremony honoring Native Americans and Hawaiians lost to AIDS
SAN FRANCISCO - March 21, 2021 - by Noah Christiansen - The National AIDS Memorial launched a Virtual Quilt Exhibition to raise greater awareness about rising HIV diagnosis rates in Native American and Hawaiian communities. The kick-off event was held at the National AIDS Memorial Grove which is located at the de Laveaga Dell in eastern Golden Gate Park in San Francisco on Saturday.
Long-time gay rights activist Carmichael 'opened doors, found collaborators' in Springfield
Mar 21, 2021 - by Noah Christiansen - Long-time Springfield activist Buff Carmichael, who pushed for marriage equality in Illinois and the creation of the AIDS Memorial in Lincoln Park, died early Sunday morning, his pastor the Rev. Martin Woulfe announced.
He was 73 and surrounded by family members at his home, Woulfe said.
Promising uptake of HIV self-testing in Africa
19 March 2021 - HIV self-testing is found to be more popular than standard testing, particularly among men, but accessing treatment after a positive result is an issue.
An evidence review of 11 HIV self-testing trials in East and Southern Africa has found promising uptake among many groups, particularly men.
AHF Salutes US Pledges on COVID-19 and AIDS
March 19, 2021 - WASHINGTON--(BUSINESS WIRE)-- AIDS Healthcare Foundation (AHF), the largest global HIV/AIDS organization, praised today the United States government for recently approving $3.5 billion in new appropriations for the Global Fund to Fight AIDS, Tuberculosis and Malaria and $250 million for the President's Emergency Plan for AIDS Relief (PEPFAR) as an expression of American commitment to global public health solidarity during the COVID-19 pandemic.
AIDS Memorial Quilt Virtual Exhibition and Stories Raise Awareness About Rise in HIV Infection Rates in Certain Native Community Populations
San Francisco, March 19, 2021 (GLOBE NEWSWIRE) -- March 20th is National Native HIV/AIDS Awareness Day (NNHAAD), a national mobilization effort designed to encourage American Indians, Alaska Natives and Native Hawaiians across the United States and Territorial Areas to increase their awareness, get tested, get involved in prevention efforts and be treated for HIV..
Disappointment and hope from two HIV prevention trials
MARCH 18, 2021 - An antibody infusion being tested for preventing HIV does not seem to thwart most infections—but its success against certain strains of the virus suggests researchers are on the right track.
HIV: An antidiabetic drug to reduce chronic inflammation
18-MAR-2021 - Researchers at the CRCHUM find that metformin could help people living with HIV who are being treated with antiretroviral therapy
Metformin, a drug used to treat type-2 diabetes, could help reduce chronic inflammation in people living with HIV (PLWH) who are being treated with antiretroviral therapy (ART), according to researchers at the University of Montreal Hospital Research Centre (CRCHUM).
The Poignant Beauty of Instagram's AIDS Memorial
MARCH 17, 2021 - BY JOHN CASEY - Haunting photos, personal stories, and heartbreak reveal boundless love.
There has been a secret and often unsaid guilt that has hung over me through my life. I am old enough to have lived through and survived the AIDS crisis of the 1980s and '90s. I was also left unscathed, with no scars, wounds or grief from caring for, caring about, or losing a loved one. AIDS did not come near me, and I did not go near it.
GAY HISTORY – March 18, 1986: William F. Buckley, Jr. Proposes Tattooing All “AIDS Carriers” in New York Times Op-Ed
MARCH 17, 2021 - Will Kohler - On March 18th, 1986 two op-eds appeared in The New York Times’s editorial page under the heading, “Critical Steps in Combating the AIDS Epidemic.” One was written by Harvard Law professor Alan Dershowitz, and the other by Buckley. Dershowitz’s column, in keeping with the general hysteria of the day, was not without its alarmist elements. He repeated the belief that “AIDS may, in fact, be transmissible by tears, saliva, bodily fluids and mosquito bites” — a contention that was quickly refuted by those more familiar with the disease. But he also pleaded that “the flow of solid data should not be polluted by personal moralism. … We have a right to know the hard facts about AIDS, unvarnished by moralistic prejudgments.”
Street renamed after Bianca Paige; longtime performer and AIDS activist
NASHVILLE, TN (WSMV)- MAR 17, 2021 - FORREST SANDERS - A community long hoped this day would come. Now that it's arrived, they couldn't be more proud. An honor is coming for a voice for important causes.
Four-days-on, three-days-off treatment regimen still looks effective after two years
16 March 2021 - Liz Highleyman - Taking antiretroviral medication four consecutive days each week followed by a three-day break maintained viral suppression as well as a daily regimen, according to 96-week follow-up results presented last week at the virtual Conference on Retroviruses and Opportunistic infection CROI).
Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV
15-MAR-2021 - – Collaboration to Focus on Oral and Injectable Formulations of Lenacapavir and Islatravir –
– Agreement Brings Together Potentially Complementary Medicines in Late-Stage Development with the Goal to Provide Innovative, Long-Acting Treatments in HIV –
March 15, 2021 - FOSTER CITY, Calif.--(BUSINESS WIRE) - Gilead Sciences, Inc.(Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that they have entered into an agreement to co-develop and co-commercialize long-acting treatments in HIV that combine Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s investigational nucleoside reverse transcriptase translocation inhibitor, islatravir,into a two-drug regimen with the potential to provide new, meaningful treatment options for people living with HIV.
HIV research: Increased weight gain with TAF medication
15-MAR-2021 - In Switzerland about 17 000 people are living with an HIV infection, worldwide there are about 38 million. Today, the disease can be treated so successfully that a normal life can be ensured to a great extent. However, weight increases are often observed at the beginning of HIV therapy due to adaptations of the metabolism, which are part of a successful therapy. Therefore, body weight control plays an important role in HIV therapy. It is important, for example, to avoid metabolic problems that can lead to heart attacks or diabetes over the long term.
Switching from TDF- to TAF-containing ART associated with the development of obesity in people living with HIV
15-MAR-2021 - Switching from antiretroviral therapy (ART) containing tenofovir disoproxil fumarate (TDF) to ART containing tenofovir alafenamide (TAF) is associated with increased risk for significant weight increases, obesity, and rising blood lipid levels in people living with HIV. In contrast to most previous studies that were performed among treatment-naive patients, the changes in weight in the present study could not be attributed to better health due to starting HIV treatment as the patients studied were already taking ART with TDF for 6 months or longer. These findings from a cohort study are published in Annals of Internal Medicine.
New Phase 1 Clinical Trial Will Evaluate Whether Army-developed Adjuvant Boosts Immune Response to Experimental HIV Vaccines
March 15, 2021 - A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family of adjuvants developed by scientists with the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research.
Injectable HIV medications must be practical and affordable, conference hears
15 March 2021 - Roger Pebody - More sensitive tests for HIV infection will also be required
HIV treatment advances in the last decade were dominated by potent integrase inhibitors and single-tablet regimens, but the next decade promises to be an era of long-acting products, Professor Diane Havlir said at a panel discussion at the Conference on Retroviruses and Opportunistic Infections (CROI 2021) last week.
President Biden vowed to end the HIV epidemic by 2025 – but how realistic is that goal?
March 13, 2021 - By David Hudson - On the campaign trail last year, Joe Biden made an election pledge to end the HIV epidemic in the United States by 2025.
That’s a five-year improvement on former President Donald Trump’s aim to end the epidemic by 2030. Now that Biden’s in the White House, how realistic is that goal?
Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years
12 March 2021 - Liz Highleyman - Long-acting cabotegravir (Vocabria) and rilpivirine (Rekambys) injections maintain viral suppression for two years, according to follow-up study results presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI).
RESEARCHERS BOOST THE POTENCY OF AN HIV-1 ANTIBODY, TRACING NEW POTENTIAL PATHWAYS FOR VACCINE DEVELOPMENT
LAWRENCE - March, 11, 2021 - Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.
“AIDS vaccine development has been a decades-long challenge partly because our immune systems have difficulty recognizing all the diverse variants of the rapidly mutating HIV virus, which is the cause of AIDS,” said Brandon DeKosky, assistant professor of pharmaceutical chemistry and chemical & petroleum engineering at the University of Kansas.
mRNA vaccine protects monkeys against HIV-like virus
11 March 2021 - Liz Highleyman - The same messenger RNA (mRNA) approach used for the highly effective Pfizer-BioNTech and Moderna COVID-19 vaccines also shows promise for protection against HIV, according to a presentation this week at the virtual Conference on Retroviruses and Opportunistic Infections.
‘An accelerated cauldron of evolution’: Covid-19 patients with cancer, HIV, may play a role in emergence of variants
March 11, 2021 - By Ariana Eunjung Cha - Some hospitalized patients with weakened immune systems were shown to have mutating viruses months before the variants were discovered in the outside world
Deepa Bhojwani recalled feeling lucky her 2-year-old cancer patient with covid-19 bounced back quickly after being seen for a fever in the emergency department at Children’s Hospital Los Angeles. But in the months that followed, an unnerving thing happened.
National AIDS Memorial Announces First Recipient of the Mary Bowman Arts in Activism Award
San Francisco, March 10, 2021 (GLOBE NEWSWIRE) - Applications for 2021 Award Now Being Accepted for social justice program funded through the support of ViiV Healthcare
The National AIDS Memorial has announced Isabel Fatima (Ima) Diawara of Los Angeles as the first recipient of the Mary Bowman Arts in Activism Award. The newly created and inspiring program, funded through a multi-year grant from ViiV Healthcare, offers support to artist-activists who are working and committed to making a difference in the fight against HIV/AIDS.
Second known person to naturally cure their HIV infection is discovered in Argentina raising future hopes for millions of other sufferers
10 March 2021 - By CHRIS JEWERS - The second-known person to naturally cure their HIV infection has been discovered by scientists in Argentina, raising hopes for a future cure.
How the AIDS epidemic can inform our handling of COVID-19
TORONTO - Mar 10, 2021 - Brooke Taylor - Grassroots activism was a driving force when informing the public about the HIV/AIDS epidemic information, and that same sort of messaging may be the key in sharing clear and concise messaging about the COVID-19 pandemic.
AIDS activist Tryfan Morys Eibhlyn Llwyd dies
Mar 10, 2021 - by Tyler Breisacher - AIDS activist and longtime anti-imperialist organizer Tryfan Morys Eibhlyn Llwyd died March 3 in Louisville, Kentucky at the age of 70. Survivors said the death was due to natural causes, and not related to COVID-19.
When Llwyd, who identified as nonbinary or genderqueer, lived in San Francisco, they were one of the central figures in the emergence of militant AIDS activism in San Francisco, starting with the AIDS Action Pledge in 1986 (which became ACT UP/San Francisco in 1988), noted queer historian Gerard Koskovich.
Therapeutic vaccine shows potential for HIV control off treatment in early study
10 March 2021 - Keith Alcorn - A therapeutic vaccine allowed some people with HIV to interrupt treatment for at least 22 weeks and maintain very low viral load, Dr Beatriz Mothe of the IrsiCaixa Institute for AIDS Research, Badalona, Spain, told the virtual Conference on Retroviruses and Opportunistic Infections (CROI 2021) today.
HIV capsid inhibitor offers new option for people with highly resistant HIV
10 March 2021 - Liz Highleyman
- Lenacapavir, an experimental HIV capsid inhibitor, led to rapid viral load reduction in highly treatment-experienced people with multidrug-resistant virus, according to a study presented yesterday at the virtual Conference on Retroviruses and Opportunistic Infections (CROI 2021).
amfAR Announces 2021 Mathilde Krim Fellowship Recipients
NEW YORK, March 9, 2021 - New research fellows harness powerful technologies in support of HIV vaccine and latency studies
amfAR, The Foundation for AIDS Research, has announced the 2021 recipients of the Mathilde Krim Fellowship in Basic Biomedical Research. The fellowships will support an HIV vaccine study by Aleksandar Antanasijevic, Ph.D., of The Scripps Research Institute, La Jolla, CA, and a study of the genes involved in maintaining HIV latency by Ujjwal Rathore, Ph.D., of the Gladstone Institutes, San Francisco, CA. The researchers were each awarded $150,000 over two years.
Group led by UCLA professor awarded $8.8 million for HIV intervention using mobile app
March 9, 2021 - by Brad Smith - NIH-funded project aims to prevent infection among high-risk transgender women
A team of researchers co-led by UCLA Fielding School of Public Health epidemiology professor Matthew Mimiaga has received an $8.8 million grant from the National Institute of Allergy and Infectious Diseases to conduct a nationwide study aimed at reducing the spread of HIV, the virus that causes AIDS, among young transgender women through the use of a mobile app.
Puerto Rico: New AHF Carolina Healthcare Center and AHF Pharmacy to Open March 9 - Paseo del Prado Shopping Center
March 09, 2021 - SAN JUAN, Puerto Rico--(BUSINESS WIRE)-- New state-of-the-art facilities aim to serve those whose access to HIV/AIDS care and services still suffer from fallout from 2017’s Hurricane Maria as well as the COVID-19 pandemic
AHF’s newest site includes an AHF Healthcare Center in Carolina (relocating from Trujillo Alto in San Juan) and an AHF Pharmacy Access Center, providing HIV/AIDS healthcare and pharmacy services as well as HIV testing and treatment and STD/STI treatment and preventionAIDS Healthcare Foundation (AHF), the world’s largest global AIDS organization, is proud to announce expansion of its services delivering state-of-the-art HIV/AIDS medical care and pharmacy services to patients regardless of their insurance status or ability to pay at its newest site in Carolina, Puerto Rico. AHF currently cares for over 1.5 million patients in 45 countries around the globe.
Large numbers now on Descovy PrEP in the United States
9 March 2021 - Roger Pebody - In the year following the US approval of emtricitabine/TAF (Descovy) as PrEP in October 2019, 29% of existing PrEP users switched to the newer formulation and 36% of new PrEP users started on it. Dr Karen Hoover of the Centers for Disease Control and Prevention presented these data, based on a large pharmacy database, to the virtual Conference on Retroviruses and Opportunistic Infections (CROI 2021) this week.
Study: Increase in taking HIV meds using Amazon Prime model
March 8, 2021 - Study took place in KwaZulu Natal, South Africa, among 162 people living with HIV.
Home delivery of HIV medicines in South Africa significantly increased viral suppression compared to those who received clinical care, according to a study by researchers at the University of Washington School of Medicine.
Greater Tobacco Use Linked to Higher Levels of Inflammation in HIV-positive People
March 8th, 2021 - AMHERST, Mass. - UMass Amherst study points to health benefits from reducing cigarette smoking
Inflammation in the body has been linked to the intensity of tobacco smoking among people with HIV, according to a team of University of Massachusetts Amherst researchers.
Researchers Identify Basic Mechanisms that Regulate HIV Expression
March 8th, 2021 - Despite the positive advances that anti-human immunodeficiency virus (HIV) therapy, commonly called anti-retroviral therapy (ART) or highly active antiretroviral therapy (HAART), has had on the life expectancy of HIV-positive people, finding a cure for HIV or acquired immunodeficiency syndrome (AIDS) has remained elusive.
Merck Presents Results from Phase 1 Trial Evaluating Investigational Islatravir Subdermal Implant for the Prevention of HIV-1 Infection at CROI 2021
March 8, 2021 - KENILWORTH, N.J.--(BUSINESS WIRE)-- Company to Proceed with Phase 2 Development Program for Islatravir Subdermal Implant
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a Phase 1 study evaluating the safety, tolerability and pharmacokinetics (PK) of the company’s investigational subdermal drug-eluting implant with potential for extended administration of islatravir for pre-exposure prophylaxis (PrEP) of HIV-1 infection.
The woman with HIV helping others have a 'good death'
March 8, 2021 - By Megha Mohan - Thembi Nkambule has been there for hundreds of people dying from Aids in Eswatini - a country where one in four people have HIV. These are the lessons she has learned on what it means to have "a good death".
UN appreciates Iran’s ‘leading role’ in fight against AIDS
March 8, 2021 - TEHRAN – The Joint United Nations Program on HIV/AIDS (UNAIDS) has praised Iran’s leading role in the fight against the virus.
UNAIDS executive director Winnie Byanyima, in a letter to Esmaeil Baghaei-Hamaneh, permanent representative to the UN in Geneva, appreciated Iran for its efforts in eradication of HIV and welcomed a visit to the country.
One Size Doesn’t Fit All When It Comes to Products for Preventing HIV from Anal Sex
PITTSBURGH, 6 March 2021 - After “trying on” three placebo methods for the delivery of a rectal microbicide, study participants said they could see all of them – a douche, rectal suppository and fast-dissolving rectal insert – fitting into their daily lives. These results, which also identified the product attributes most important to participants, underscore the importance of developing a range of HIV prevention products for people who practice anal sex.
Virginia is poised to reform its HIV criminalization laws. Is the rest of the U.S. next?
March 5, 2021 - By Dan Avery - “Being HIV positive is itself not a threat to public safety,” state Sen. Jennifer McClellan, a Democrat, said.
Virginia lawmakers have approved legislation modernizing laws around HIV exposure.
Ten-year Italian study shows that people with HIV remain undetectable for 97% of the time
5 March 2021 - Michael Carter - Long-term monitoring of people with HIV with an undetectable viral load has shown that viral suppression is rarely lost, enforcing the validity of 'U=U' (Undetectable equals Untransmittable) messaging, according to Italian research published in the online edition of AIDS. The study involved over 8000 HIV-positive individuals taking antiretroviral therapy (ART) and with viral suppression (a viral load below 200) at baseline. Regular monitoring of viral load (at least twice a year for most) showed that viral load remained suppressed 97% of the time.
Help Celebrate Black Women in the HIV Movement
MARCH 05 2021 - By Desirée Guerrero - The Positive Women’s Network announces the first official day honoring Black women in the continued fight against HIV.
Black women have long been the silent soldiers in the fight against HIV, often selflessly devoting their time, love, and energy to serve their local HIV communities. But now, one organization is dedicating a special day to honor these hard-working, courageous women. Next Friday, March 12, will be a day to “Celebrate & Honor Black Women in the HIV Movement.” The event is being put on by the Positive Women’s Network (PWN), “a nationwide community of women living with HIV,” as stated on its website. “Our mission is to prepare and involve all women living with HIV, in all our diversity, including gender identity and sexual expression, in all levels of policy and decision-making.”
Shock as new HIV infections in youths double in 7 years
05 March 2021 - Six in every ten infections now among young people below 30 years
The Ministry of Health and Health CECs will conduct nationwide HIV campaigns after the latest statistics showed extremely high new infections in youths.
Fred Hutch at CROI: COVID-19 vaccine efficacy trials, T-cell immunity following vaccination, immune responses to SARS-CoV-2, and late-breaking science on HPV, HIV and long-term antiretroviral therapy
SEATTLE —Mar. 4, 2021 - Conference on Retroviruses and Opportunistic Infections to be held virtually March 6 – 10, 2021
Fred Hutchinson Cancer Research Center experts will present research on SARS-CoV-2 infection and immunity, and COVID-19 vaccine trial design at the Conference on Retroviruses and Opportunistic Infections 2021. The meeting, which will be held virtually March 6-10, also will feature findings from the Uganda Cancer Institute-Fred Hutch Cancer Centre.
This Week in HIV Research: The Unsung Opportunities of Long-Acting Antiretrovirals
March 4, 2021 - Barbara Jungwirth - Myles Helfand - Since receiving U.S. approval in January, much of the conversation around the long-acting injectable cabotegravir/rilpivirine (Cabenuva) has centered around the types of patients who may be the best candidates for switching off their current oral daily regimen and onto the new monthly injection. Meanwhile, there’s plenty of buzz around the eventual greenlight of long-acting injectable cabotegravir as pre-exposure prophylaxis (PrEP).
A Cream Bests Surgery as Treatment for Abnormal Anal Cells in Men With HIV
March 4, 2021 - By Heather Boerner - While researchers try to figure out whether treating early anal tissue changes can prevent cancer, some are investigating treatments.
Treating high-risk anal tissue changes with a self-administered 5% imiquimod cream resulted in fewer follow-up treatments and more total remission of potentially precancerous cells compared with surgery alone.
Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021
March 3, 2021 - KENILWORTH, N.J.-- (BUSINESS WIRE) -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today upcoming presentations from its HIV clinical development programs that will be featured during the 2021 Conference on Retroviruses and Opportunistic Infections (CROI 2021), taking place virtually from March 6 – 10, 2021. Presentations will include new data for islatravir, the company’s investigational nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is being developed for HIV treatment and prevention. Merck will share late-breaking Phase 1 study results evaluating a new prototype subdermal drug-eluting implant for extended administration of islatravir for pre-exposure prophylaxis (PrEP). This data will also be featured in the CROI virtual press conference. Throughout the conference, Merck will also share pharmacokinetic (PK) threshold and dose selection data for once-monthly oral islatravir for PrEP and model-informed dose selection data for the Phase 2b study of islatravir administered with MK-8507, the company’s investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), for oral once-weekly treatment of HIV-1 infection in adults. There will also be updates from the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network evaluating DELSTRIGO™ (doravirine 100 mg/lamivudine 300 mg/tenofovir disoproxil fumarate 300 mg) in HIV-infected adolescents ages 12 to 18 years and weighing at least 45 kg.
BlueCity Partners with UNAIDS for Zero Discrimination Day Campaign
BEIJING, March 02, 2021 (GLOBE NEWSWIRE) --Brand calls for ending inequalities in Asia Pacific with a monthlong series of
BlueCity, a world-leading LGBTQ community platform providing a full suite of services to foster connections and enhance the well-being of the LGBTQ community, has partnered with UNAIDS on Zero Discrimination Day, March 1, with a monthlong series of awareness-building events aiming to help end discrimination and inequality across societies in Asia-Pacific.
Gilead to Present New Data at CROI 2021 Demonstrating the Company's Commitment to Addressing Urgent Global Health Needs
March 02, 2021 - FOSTER CITY, Calif. --(BUSINESS WIRE) - -- 19 Abstracts Will Feature the Latest Advances in the Company’s HIV, COVID-19 and Viral Hepatitis Research Programs --
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new data from the company’s HIV, hepatitis C virus (HCV), and COVID-19 research and development programs at the 28th Conference on Retroviruses and Opportunistic Infections (virtual CROI 2021) taking place from March 6-10. The breadth of data at the meeting reflects Gilead’s longstanding commitment to applying its scientific innovation toward addressing some of the world’s most challenging viruses and advancing global health.
New MHRP pre-clinical SHIV remission study shows progress in delaying viral load rebound
March 1, 2021 - A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.
Message from the UNAIDS Executive Director on Zero Discrimination Day 2021
March 1, 2021 - This year’s Zero Discrimination Day is an especially poignant one.
US study suggests women living with HIV should be screened earlier for non-AIDS co-morbidities
1 March 2021 - Rosalie Hayes - Women living with HIV are at greater risk of developing non-AIDS co-morbidities than their HIV-negative peers, with the difference most evident among younger women, according to US research published in Clinical Infectious Diseases. Overall, women living with HIV were 36% more likely to develop non-AIDS co-morbidities during the study period compared to women without HIV, after adjusting for demographics factors, drug and alcohol use, body mass index (BMI) and income level. This rose to 48% among women aged below 25 – a group not traditionally prioritised in co-morbidity screening guidelines.
HIV findings in DR Congo 'give hope for cure'
March 1, 2021 - The discovery of a large group of people whose bodies naturally control HIV without taking medication is leading to hopes of an eventual cure, scientists say.
The study found as many as 4% of HIV carriers in the Democratic Republic of Congo were able to suppress the virus.
2020 Elisse Zack Award for Excellence in HIV and Rehabilitation Recipient: Colleen Price
Mar 1, 2021 - Colleagues Francisco Ibáñez-?Carrasco and Kelly O'Brien, and Colleen Price speak about her receiving the 2020 Elisse Zack Award for Excellence in HIV and Rehabilitation